Welch Group, LLC - GT BIOPHARMA INC ownership

GT BIOPHARMA INC's ticker is GTBP and the CUSIP is 36254L209. A total of 38 filers reported holding GT BIOPHARMA INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Welch Group, LLC ownership history of GT BIOPHARMA INC
ValueSharesWeighting
Q3 2023$2,411
-22.7%
10,0000.0%0.00%
Q2 2023$3,120
-43.3%
10,0000.0%0.00%
Q1 2023$5,500
-37.9%
10,0000.0%0.00%
-100.0%
Q4 2022$8,857
-50.8%
10,0000.0%0.00%0.0%
Q3 2022$18,000
-40.0%
10,0000.0%0.00%
-50.0%
Q2 2022$30,000
+3.4%
10,0000.0%0.00%0.0%
Q1 2022$29,000
-6.5%
10,0000.0%0.00%0.0%
Q4 2021$31,000
-53.7%
10,0000.0%0.00%
-60.0%
Q3 2021$67,00010,0000.01%
Other shareholders
GT BIOPHARMA INC shareholders Q2 2023
NameSharesValueWeighting ↓
Baskin Financial Services Inc. 151,354$360.00%
Moss Adams Wealth Advisors LLC 20,000$4,8220.00%
UBS Group AG 8,750$2,1090.00%
Compagnie Lombard Odier SCmA 50,000$12,0550.00%
OSAIC HOLDINGS, INC. 1,270$3050.00%
FMR LLC 150$360.00%
BANK OF AMERICA CORP /DE/ 508$1220.00%
WELLS FARGO & COMPANY/MN 300,697$72,4980.00%
NORTHERN TRUST CORP 32,347$7,7990.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of GT BIOPHARMA INC shareholders